LECAP Asset Management’s Quest Diagnostics DGX Stock Holding History

LECAP Asset Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,497	Closed	-$780K	–	303
2025 Q4	$780K	Buy	+4,497	New	+$819K	0.31%	126
2024 Q3	–	Sell	-20,496	Closed	-$2.81M	–	329
2024 Q2	$2.81M	Buy	+20,496	New	+$2.81M	0.61%	46
2024 Q1	–	Sell	-7,145	Closed	-$985K	–	310
2023 Q4	$985K	Buy	+7,145	New	+$939K	0.36%	110

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

LECAP Asset Management's DGX Position: Q1 2026 in Review

LECAP Asset Management sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 4,497 shares — an estimated $780K sold.

LECAP Asset Management first reported a position in DGX in Q4 2023 and held it in 3 quarters. The position peaked at $2.81M in Q2 2024. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

LECAP Asset Management reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
LECAP Asset Management sold 4,497 Quest Diagnostics shares in Q1 2026, an estimated $780K.
LECAP Asset Management first reported a position in Quest Diagnostics in Q4 2023 and held it in 3 quarters.
LECAP Asset Management's Quest Diagnostics position peaked at $2.81M in Q2 2024.
1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on LECAP Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.